vs
合众银行（FSBC）与Phathom Pharmaceuticals, Inc.（PHAT）财务数据对比。点击上方公司名可切换其他公司
Phathom Pharmaceuticals, Inc.的季度营收约是合众银行的1.3倍（$57.6M vs $45.1M）
合众银行是总部设在美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的银行。它旗下核心运营实体为美国银行全国协会，以US Bank品牌开展业务，提供银行、投资、抵押等金融服务。
Phathom Pharmaceuticals是一家临床阶段生物制药公司，专注于研发和商业化胃肠道疾病的创新疗法，其核心候选产品针对酸相关疾病、炎症性肠病等适应症，主要服务北美及欧洲地区的患者群体。
FSBC vs PHAT — 直观对比
营收规模更大
PHAT
是对方的1.3倍
$45.1M
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $57.6M |
| 净利润 | $18.6M | — |
| 毛利率 | — | 86.7% |
| 营业利润率 | — | — |
| 净利率 | 41.3% | — |
| 营收同比 | — | 94.1% |
| 净利润同比 | 42.0% | 71.6% |
| 每股收益（稀释后） | $0.87 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSBCPHAT
| Q1 26 | $45.1M | — | ||
| Q4 25 | $43.5M | $57.6M | ||
| Q3 25 | $41.3M | $49.5M | ||
| Q2 25 | $38.3M | $39.5M | ||
| Q1 25 | $35.3M | $28.5M | ||
| Q4 24 | $35.2M | $29.7M | ||
| Q3 24 | $31.8M | $16.4M | ||
| Q2 24 | $30.7M | $7.3M |
净利润FSBCPHAT
| Q1 26 | $18.6M | — | ||
| Q4 25 | $17.6M | — | ||
| Q3 25 | $16.3M | $-30.0M | ||
| Q2 25 | $14.5M | $-75.8M | ||
| Q1 25 | $13.1M | $-94.3M | ||
| Q4 24 | $13.3M | — | ||
| Q3 24 | $10.9M | $-85.6M | ||
| Q2 24 | $10.8M | $-91.4M |
毛利率FSBCPHAT
| Q1 26 | — | — | ||
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% |
营业利润率FSBCPHAT
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 53.8% | -30.8% | ||
| Q2 25 | 52.4% | -151.7% | ||
| Q1 25 | 52.0% | -276.5% | ||
| Q4 24 | 55.1% | — | ||
| Q3 24 | 48.0% | -433.0% | ||
| Q2 24 | 49.4% | -1055.4% |
净利率FSBCPHAT
| Q1 26 | 41.3% | — | ||
| Q4 25 | 40.6% | — | ||
| Q3 25 | 39.6% | -60.5% | ||
| Q2 25 | 37.9% | -191.9% | ||
| Q1 25 | 37.1% | -330.7% | ||
| Q4 24 | 37.9% | — | ||
| Q3 24 | 34.4% | -523.3% | ||
| Q2 24 | 35.2% | -1248.6% |
每股收益（稀释后）FSBCPHAT
| Q1 26 | $0.87 | — | ||
| Q4 25 | $0.83 | — | ||
| Q3 25 | $0.77 | $-0.41 | ||
| Q2 25 | $0.68 | $-1.05 | ||
| Q1 25 | $0.62 | $-1.31 | ||
| Q4 24 | $0.61 | — | ||
| Q3 24 | $0.52 | $-1.32 | ||
| Q2 24 | $0.51 | $-1.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $644.4M | $130.0M |
| 总债务越低越好 | — | $209.1M |
| 股东权益账面价值 | $458.5M | $-438.2M |
| 总资产 | $5.0B | $259.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FSBCPHAT
| Q1 26 | $644.4M | — | ||
| Q4 25 | — | $130.0M | ||
| Q3 25 | — | $135.2M | ||
| Q2 25 | — | $149.6M | ||
| Q1 25 | — | $212.3M | ||
| Q4 24 | — | $297.3M | ||
| Q3 24 | — | $334.7M | ||
| Q2 24 | — | $276.2M |
总债务FSBCPHAT
| Q1 26 | — | — | ||
| Q4 25 | — | $209.1M | ||
| Q3 25 | — | $207.1M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $203.2M | ||
| Q4 24 | — | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | — | $174.4M |
股东权益FSBCPHAT
| Q1 26 | $458.5M | — | ||
| Q4 25 | $445.8M | $-438.2M | ||
| Q3 25 | $431.3M | $-422.5M | ||
| Q2 25 | $416.7M | $-405.8M | ||
| Q1 25 | $406.5M | $-338.4M | ||
| Q4 24 | $396.6M | $-253.6M | ||
| Q3 24 | $389.9M | $-187.1M | ||
| Q2 24 | $380.5M | $-233.8M |
总资产FSBCPHAT
| Q1 26 | $5.0B | — | ||
| Q4 25 | $4.8B | $259.1M | ||
| Q3 25 | $4.6B | $240.3M | ||
| Q2 25 | $4.4B | $250.2M | ||
| Q1 25 | $4.2B | $294.2M | ||
| Q4 24 | $4.1B | $378.3M | ||
| Q3 24 | $3.9B | $387.0M | ||
| Q2 24 | $3.6B | $319.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-166.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-167.0M |
| 自由现金流率自由现金流/营收 | — | -290.0% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-328.9M |
8季度趋势，按日历期对齐
经营现金流FSBCPHAT
| Q1 26 | — | — | ||
| Q4 25 | $72.6M | $-166.8M | ||
| Q3 25 | $18.8M | $-14.1M | ||
| Q2 25 | $17.8M | $-62.7M | ||
| Q1 25 | $15.5M | $-84.9M | ||
| Q4 24 | $51.8M | $-266.8M | ||
| Q3 24 | $17.5M | $-63.6M | ||
| Q2 24 | $16.0M | $-70.7M |
自由现金流FSBCPHAT
| Q1 26 | — | — | ||
| Q4 25 | $71.4M | $-167.0M | ||
| Q3 25 | $18.6M | $-14.1M | ||
| Q2 25 | $17.5M | $-62.8M | ||
| Q1 25 | $15.4M | $-84.9M | ||
| Q4 24 | $51.2M | $-266.9M | ||
| Q3 24 | $17.3M | $-63.6M | ||
| Q2 24 | $15.8M | $-70.8M |
自由现金流率FSBCPHAT
| Q1 26 | — | — | ||
| Q4 25 | 164.3% | -290.0% | ||
| Q3 25 | 45.0% | -28.6% | ||
| Q2 25 | 45.8% | -159.0% | ||
| Q1 25 | 43.5% | -297.9% | ||
| Q4 24 | 145.5% | -899.8% | ||
| Q3 24 | 54.5% | -389.0% | ||
| Q2 24 | 51.6% | -966.2% |
资本支出强度FSBCPHAT
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | 0.4% | ||
| Q3 25 | 0.5% | 0.1% | ||
| Q2 25 | 0.6% | 0.2% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 1.8% | 0.5% | ||
| Q3 24 | 0.7% | 0.3% | ||
| Q2 24 | 0.7% | 0.6% |
现金转化率FSBCPHAT
| Q1 26 | — | — | ||
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.15× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 1.18× | — | ||
| Q4 24 | 3.89× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSBC
| Net Interest Income | $43.5M | 96% |
| Noninterest Income | $1.6M | 4% |
PHAT
暂无分部数据
